| Bioactivity | Itriglumide (CR 2945) is an anthranilic acid derivative. Itriglumide is a potent and selective CCKB receptor antagonist, with an IC50 of 2.3 nM. Itriglumide antagonizes the response to gastrin in a dose-dependent manner with an IC50 of 5.9 nM. Itriglumide shows antisecretory and antiulcer activity[1]. |
| CAS | 201605-51-8 |
| Formula | C33H38N2O4 |
| Molar Mass | 526.67 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Makovec F, et al. Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist. Eur J Pharmacol. 1999 Mar 12;369(1):81-90. |
Itriglumide
CAS: 201605-51-8 F: C33H38N2O4 W: 526.67
Itriglumide (CR 2945) is an anthranilic acid derivative. Itriglumide is a potent and selective CCKB receptor antagonist,
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.